<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04055909</url>
  </required_header>
  <id_info>
    <org_study_id>MOT-C-203</org_study_id>
    <secondary_id>2018-004827-36</secondary_id>
    <nct_id>NCT04055909</nct_id>
  </id_info>
  <brief_title>Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock</brief_title>
  <acronym>ASTONISH</acronym>
  <official_title>Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock. A Randomized, Double-blind, Placebo Controlled Dose Selection Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inotrem</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inotrem</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, double-blind, placebo-controlled dose-selection study in which two&#xD;
      doses of nangibotide are tested versus placebo.&#xD;
&#xD;
      All patients with a diagnosis of septic shock will be considered for study participation. All&#xD;
      potential study patients will receive standard of care for the treatment of septic shock.&#xD;
&#xD;
      After screening for eligibility, patients meeting all inclusion and no exclusion criterion&#xD;
      will be randomized. Patients will be randomized to one of three treatment arms.&#xD;
&#xD;
      Treatment with study drug must be initiated as early as possible, but no later than 24 hours&#xD;
      after the onset of septic shock, defined by the start of vasopressor therapy.&#xD;
&#xD;
      Patients will be treated for at least 3 days with study drug. After the first 3 days of&#xD;
      treatment, patients still requiring vasopressor will be treated until 24 hours after&#xD;
      vasopressor withdrawal with a maximum treatment duration of 5 days.&#xD;
&#xD;
      Patients will be assessed at the End of Study (EoS) visit at day 28. After the last patient's&#xD;
      day 28 visit, the study will be analyzed. Additional follow up (FU) visits will be conducted&#xD;
      after 90 days, 6 and 12 months.&#xD;
&#xD;
      The objective of the study ist to compare the safety, tolerability and efficacy of two doses&#xD;
      of nangibotide versus placebo, when given in addition to standard of care.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 13, 2019</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sequential organ failure assessment (SOFA) score</measure>
    <time_frame>day 5</time_frame>
    <description>Change of total SOFA score from baseline to day 5 (in the subgroup defined by patients with elevated sTREM-1 baseline levels and in the overall population)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>day 28</time_frame>
    <description>Survival and all-cause mortality on D28</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Shock, Septic</condition>
  <arm_group>
    <arm_group_label>nangibotide 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>nangibotide 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>nangibotide low dose</intervention_name>
    <description>nangibotide 0.3 mg/kg/h</description>
    <arm_group_label>nangibotide 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>nangibotide high dose</intervention_name>
    <description>nangibotide 1.0 mg/kg/h</description>
    <arm_group_label>nangibotide 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>matching placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Provide written informed consent&#xD;
&#xD;
          2. Age 18 to 85 years (inclusive)&#xD;
&#xD;
          3. Documented or suspected infection: lung, abdominal or urinary tract infection (UTI) in&#xD;
             the elderly (≥65 years)&#xD;
&#xD;
          4. Organ dysfunction defined as acute change in total SOFA score ≥ 2 points&#xD;
&#xD;
          5. Refractory hypotension requiring vasopressors to maintain MAP ≥65mm Hg despite&#xD;
             adequate volume resuscitation&#xD;
&#xD;
          6. Hyperlactatemia (blood lactate &gt;2 mmol/L or 18 mg/dL).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Previous episode of septic shock requiring vasopressor administration within current&#xD;
             hospital stay&#xD;
&#xD;
          2. Underlying concurrent immunodepression with anti-CD52 alemtuzumab (Campath) or&#xD;
             glucocorticoids &gt;75 mg prednisone daily or equivalent for more than 7 days&#xD;
&#xD;
          3. Immunosuppressive therapy related to recent (&lt;6 months) transplantation&#xD;
&#xD;
          4. Cancer chemotherapy (&lt;3 months) implying an immunodepression&#xD;
&#xD;
          5. Known HIV infection with low CD4 cell count (&lt;200) for at least 6 months&#xD;
&#xD;
          6. Known pregnancy (positive urine or serum pregnancy test)&#xD;
&#xD;
          7. Shock of any other cause, e.g. hypotension related to gastrointestinal bleeding&#xD;
&#xD;
          8. Ongoing documented or suspected endocarditis, history of prosthetic heart valves&#xD;
&#xD;
          9. Prolonged QT syndrome&#xD;
&#xD;
         10. End-stage neurological disease&#xD;
&#xD;
         11. End-stage cirrhosis (Child Pugh Class C)&#xD;
&#xD;
         12. Acute Physiology and Chronic Health Evaluation (APACHE II) score &lt;15 or ≥ 34&#xD;
&#xD;
         13. Home oxygen therapy on a regular basis for &gt; 6 h/day&#xD;
&#xD;
         14. Recent cardiopulmonary resuscitation (CPR) (within current hospital stay)&#xD;
&#xD;
         15. Body mass index (BMI) ≥ 40 kg/m2or weight ≥ 130 kg&#xD;
&#xD;
         16. Moribund patients&#xD;
&#xD;
         17. Decision to limit full care taken before obtaining informed consent&#xD;
&#xD;
         18. Participation in another interventional study in the 3 months prior to randomization&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Jacques Garaud, MD</last_name>
    <role>Study Director</role>
    <affiliation>CEO and Medical Officer</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Jacques Garaud, MD</last_name>
    <phone>+33 (0)9 66 81 79 00</phone>
    <email>astonish@inotrem.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cliniques Universitaires Saint-Luc</name>
      <address>
        <city>Bruxelles</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre-Francois Laterre, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ziekenhuis Oost-Limburg</name>
      <address>
        <city>Genk</city>
        <zip>3600</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tom Fivez, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UZ Gent</name>
      <address>
        <city>Gent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joris Vermassen, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier Jolimont-Lobbes</name>
      <address>
        <city>La Louvière</city>
        <zip>7100</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent Huberlant, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Marie Curie</name>
      <address>
        <city>Lodelinsart</city>
        <zip>6042</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Fagnoul, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Saint-Pierre</name>
      <address>
        <city>Ottignies</city>
        <zip>1340</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry Dugernier, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU UCL Namur asbl</name>
      <address>
        <city>Yvoir</city>
        <zip>5530</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain-Michel Dive, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nordsjællandshospital Hillerød</name>
      <address>
        <city>Hillerod</city>
        <zip>DK-3400</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Morten Bestle, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helsinki University Hospital Adult ICU PPDS</name>
      <address>
        <city>Helsinki</city>
        <zip>PL 340</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ville Pettila, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kuopion Yliopistollinen sairaala</name>
      <address>
        <city>Kuopio</city>
        <zip>PO BOX 1777</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matti Reinikainen, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tampereen yliopistollinen sairaala</name>
      <address>
        <city>Tampere</city>
        <zip>PL 2000</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ville Jalkanen, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Angers</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Asfar, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier Victor Dupouy</name>
      <address>
        <city>Argenteuil</city>
        <zip>95100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gaëtan Plantefeve, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Fleyriat</name>
      <address>
        <city>Bourg-en-Bresse</city>
        <zip>01000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Camille Bouisse, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier de Béthune</name>
      <address>
        <city>Béthune</city>
        <zip>62408</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe Vinsonneau, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Dijon - Hôpital François Mitterrand</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jena-Pierre Quenot, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHD les Oudairies</name>
      <address>
        <city>La Roche sur Yon</city>
        <zip>85925</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle Vinatier, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital de Bicêtre</name>
      <address>
        <city>Le Kremlin Bicêtre</city>
        <zip>94270</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier Monnet, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU LE Mans</name>
      <address>
        <city>Le Mans</city>
        <zip>72000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe Guitton, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU Lille - Hôpital Roger Salengro</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Saadalla Nseir, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Universitaire Dupuytren</name>
      <address>
        <city>Limoges</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno Francois, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Lyon Sud</name>
      <address>
        <city>Lyon</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julien Bohe, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Nord</name>
      <address>
        <city>Marseille</city>
        <zip>13015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent Papazian, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier de Melun</name>
      <address>
        <city>Melun</city>
        <zip>77000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mehran Monchi, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU Nancy - Hôpital Central</name>
      <address>
        <city>Nancy</city>
        <zip>54035</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sébastien Gibot, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôtel Dieu - Nanates</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jérémie Lemarié, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Nîmes</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Yves Lefrant, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital de la source</name>
      <address>
        <city>Orléans</city>
        <zip>45067</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mai-Anh Nay, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Lariboisière</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandre Mebazaa, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Louis</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Haikel Oueslati, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Groupe hospitalier Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Michel Constantin, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Cochin</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Paul Mira, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU Hôpital Bretonneau</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuelle Mercier, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital d'instruction des Armées Robert Picqué</name>
      <address>
        <city>Villenave d'Ornon</city>
        <zip>33882</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Tran-Van, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St Jame's Hospital</name>
      <address>
        <city>Dublin</city>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ignacio Matin-Loeches, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galway University Hospital</name>
      <address>
        <city>Galway</city>
        <zip>H91 YR71</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>John Laffey, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Vall d'Hebrón</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ricardo Ferrer, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital del mar</name>
      <address>
        <city>Barcelone</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rosana Munoz Bermudez, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinical San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fernando Martinez Sagasti, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Dentral de Asturias</name>
      <address>
        <city>Oviedo</city>
        <zip>33011</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dolores Escudero Augusto, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Mutua de Terrassa</name>
      <address>
        <city>Terrassa</city>
        <zip>08221</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Enrique Piacentini Gomez, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital universitario DR. Peset Aleixandre</name>
      <address>
        <city>Valencia</city>
        <zip>46017</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rafael Zaragoza Crespo, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario y Politecnico la Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paula Ramirez Galleymore, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Denmark</country>
    <country>Finland</country>
    <country>France</country>
    <country>Ireland</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>August 12, 2019</study_first_submitted>
  <study_first_submitted_qc>August 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2019</study_first_posted>
  <last_update_submitted>June 29, 2021</last_update_submitted>
  <last_update_submitted_qc>June 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Septic Shock</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nangibotide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

